HOME >> BIOLOGY >> NEWS
New instrument enables remote detection of toxic algae in real time

MOSS LANDING, California Using the Environmental Sample Processor (ESP), the first in a new class of oceanographic research instrumentation, a team of MBARI scientists and engineers detected the onset and development of a harmful algal bloom (HAB).

The ESP was deployed in May as part of an ongoing, multi-institution research effort in the Gulf of Maine aimed at understanding the growth, transport, and decay of toxic blooms which can adversely affect the health of humans and wildlife. The toxic dinoflagellate, Alexandrium fundyense, was detected during the experiment at low densities of approximately 100 cells per liter of seawater.

The ESP was developed at the Monterey Bay Aquarium Research Institute (MBARI) and is designed to autonomously collect discrete subsurface water samples and concentrate microorganisms contained within those samples onto filter disks. The ESP automates application of preservatives as well as DNA and other molecular probes to the collected samples to enable identification and quantification of particular species captured.

In addition to archiving discrete samples for microscopy and nucleic acid and toxin analyses, the instrument also transmits results of probe assays in real-time to a remote location for data processing and interpretation.

This capability provides an entirely new means of remotely detecting microorganisms in the environment, enabling water quality assessments in the absence of ship-based sample collection and time-consuming laboratory analysis.

The ESP is the result of four years of teamwork between MBARI scientists and engineers, under the leadership of Chris Scholin and Gene Massion. Although the current instrument is targeted at HAB research and issues related to the health of humans and marine wildlife, it is capable of emulating a wide variety of water quality measurements.

"The exciting results from the Gulf of Maine experiment are the culmination of four years of effort at MBARI in developing t
'"/>

Contact: Gail Piper de Mesa
pdm@mbari.org
831-775-1835
Monterey Bay Aquarium Research Institute
4-Jun-2001


Page: 1 2

Related biology news :

1. New space-borne instrument to track greenhouse gases, ozone destroyers, and other pollutants
2. ESA and EADS-CASA sign contract to build instrument for the SMOS mission
3. NCAR aircraft, ground instruments to track carbon dioxide uptake
4. Nanotech instruments allow first direct observations of RNA proofreading
5. Purdue instrument to fashion custom-made proteomics chips
6. Acoustic technique could disinfect medical instruments without heat or harsh chemicals
7. MIT instrument monitors molten materials
8. ORNL conducting field test of instruments to detect lead
9. Konza Prairie instrumental in research that indicates small streams important in controlling nitrogen, preserving water quality
10. ORNL instrument could spell doom for Asian beetles
11. NASA laser instrument to aid forest management, media briefing scheduled for Oct. 12

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New instrument enables remote detection toxic algae real time

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: